| Outpatient Encounters – Telehealth and In-Person (N = 134,375) | ||
---|---|---|---|
Baseline Pre-Pandemic (N = 89,357) | Study Period During Pandemic (N = 45,018) | ||
In-person Visit (N = 89,357) | Telehealth Visit (N = 17,659) | In-person Visit (N = 27,359) | |
IRR/OR | |||
 Number of Days until the next visit | ref | 0.76 (0.75, 0.78) | 0.71 (0.70, 0.72) |
 Probability, % (0–100) | |||
  3-Day Follow-up | ref | 1.36 (1.26, 1.47) | 1.38 (1.30, 1.47) |
  7-Day Follow-up | ref | 1.36 (1.29, 1.43) | 1.51 (1.45, 1.57) |
  14-Day Follow-up | ref | 1.39 (1.33, 1.45) | 1.57 (1.52, 1.62) |
  30-Day Follow-up | ref | 1.54 (1.48, 1.61) | 1.74 (1.68, 1.79) |
Predicted Outcomes | Â | ||
 Number of Days until the next visit | 43.9 (43.6, 44.2) | 33.4 (32.9, 33.9) | 31.2 (30.8, 31.5) |
 Probability, % (0–100) | |||
  3-Day Follow-up | 6.9 (6.7, 7.1) | 9.2 (8.6, 9.7) | 9.3 (8.9, 9.7) |
  7-Day Follow-up | 17.0 (16.7, 17.2) | 21.8 (21.0, 22.5) | 23.5 (22.0, 24.1) |
  14-Day Follow-up | 30.5 (30.1, 30.8) | 37.8 (36.9, 38.6) | 40.6 (40.1, 41.3) |
  30-Day Follow-up | 52.0 (51.7, 52.4) | 62.4 (61.6, 63.2) | 65.1 (64.5, 65.7) |